Back to Search
PAUL MISCHEL, MD
MD
Anatomic Pathology & Clinical Pathology Physician
NPI: 1508892514Individual
Specialties, Licenses & Credentials
Anatomic Pathology Physician
Pathology — Anatomic Pathology
Code: 207ZP0101X
G77108(CA)
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
G77108(CA)
Research & Publications (20)
Using molecular information to guide brain tumor therapy.
PMID 16932555·Nat Clin Pract Neurol·2006
6-review
DNA-microarray analysis of brain cancer: molecular classification for therapy.
PMID 15378038·Nat Rev Neurosci·2004
6-review
Identification of molecular subtypes of glioblastoma by gene expression profiling.
PMID 12700671·Oncogene·2003
4-observational
Nerve growth factor signals via preexisting TrkA receptor oligomers.
PMID 12124278·Biophys J·2002
7-preclinical
The extracellular domain of p75NTR is necessary to inhibit neurotrophin-3 signaling through TrkA.
PMID 11150291·J Biol Chem·2001
7-preclinical
Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone.
PMID 19655089·J Neurooncol·2010
8-other
Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
PMID 19468690·J Neurooncol·2009
7-preclinical
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.
PMID 19478061·Proc Natl Acad Sci U S A·2009
8-other
Targeted therapy for malignant glioma patients: lessons learned and the road ahead.
PMID 19560740·Neurotherapeutics·2009
6-review
Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.
PMID 19561256·Radiology·2009
2-rct
Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.
PMID 19573811·Cancer Cell·2009
7-preclinical
Striking the balance between PTEN and PDK1: it all depends on the cell context.
PMID 19651981·Genes Dev·2009
7-preclinical
Neurosphere formation is an independent predictor of clinical outcome in malignant glioma.
PMID 19353526·Stem Cells·2009
7-preclinical
Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience.
PMID 19349600·Neurology·2009
8-other
Noninvasive imaging of alphaVbeta3 function as a predictor of the antimigratory and antiproliferative effects of dasatinib.
PMID 19318569·Cancer Res·2009
7-preclinical
The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.
PMID 19625624·Proc Natl Acad Sci U S A·2009
7-preclinical
A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM).
PMID 19018475·J Neurooncol·2009
3-trial
Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age.
PMID 18940004·BMC Med Genomics·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10833 LE CONTE AVE
LOS ANGELES, CA 90095 - Phone
- (310) 794-7953
Quick Facts
- NPI
- 1508892514
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile